1.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 20050100, NCT00352703
|
|
2.
|
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 65 and under
Sponsor: Other
Protocol IDs: AML99<=65 años, NCT00390715
|
|
3.
|
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: SHEBA-06-4196-MKM-CTIL, NCT00449592
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDL-3-251, MSKCC-93131, NCI-V94-0469
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-8075, NCI-D81-043-098
|
|
7.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: UCCRC-3248, NCI-D81-014-080
|
|
8.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-013-686
|
|
9.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: NCI-D82-043-188, MDA-IM-8104
|
|
10.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NCI-D82-051-605
|
|
11.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor:
Protocol IDs: SEG-LUN-81342R
|
|
12.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-GU-306
|
|
13.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor:
Protocol IDs: SAFR-CT-MM-2
|
|
14.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 55
Sponsor:
Protocol IDs: UCLA-81107522, NCI-V83-0180
|
|
15.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BGSM-62384, NCI-T87-0147D, T87-0147
|
|
16.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: NCI-85-C-62, NCI-T85-0096N, T85-0096
|
|
17.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: NCI-D81-039-767, CHP-436
|
|
18.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: UNMC-116, NCI-V85-0251
|
|
19.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-86-C-92A, NCI-NMOB-855, NCI-T86-0137N, T86-0137
|
|
20.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1586
|
|
21.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: POG-8741/42, POG-8741, POG-8742
|
|
22.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: SJCRH-AML-87, NCI-T86-0203D, T86-0203
|
|
23.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: WCCC-CO-8751, NCI-V87-0225
|
|
24.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 22
Sponsor: NCI
Protocol IDs: CCG-201
|
|
25.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1588
|
